Autres langues Rakovina Therapeutics Inc.

Actions

RKV

CA75103L1013

Marché Fermé - Toronto S.E. Autres places de cotation 16:54:38 26/04/2024			Varia. 5j.	Varia. 1 janv.
0,09 ^CAD	0,00%		0,00%	+5,88%

09/04	Rakovina Therapeutics présente ses travaux à la réunion annuelle de l'American Association Of Cancer Research	MT
2023	Rakovina Therapeutics annonce la nomination d'un membre de son conseil scientifique	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Rakovina Therapeutics Inc. Announces 2023 Financial Results and Provides Corporate Update	02:39
Rakovina Therapeutics Presents At American Association Of Cancer Research Annual Meeting	09/04
Rakovina Therapeutics Presented at American Association of Cancer Research Annual Meeting at the San Diego Convention Center Today	09/04
Accelerating New Molecule Discovery: Rakovina Therapeutics AI Integration	02/04
Rakovina Therapeutics To Host Informational Webinar on April 3, 2024	01/04
Rakovina Therapeutics Announces Strategic Pivot to AI	27/03
Rakovina Therapeutics Inc. Announces Q3 2023 Financial Results and Provides Corporate Update	28/11
Rakovina Therapeutics Announces Appointment to Scientific Advisory Board	27/11
Rakovina Therapeutics Welcomes Prof. Artem Cherkasov to the Company’s Scientific Advisory Board	27/11
Rakovina Therapeutics Welcomes Prof. Artem Cherkasov to the Company’s Scientific Advisory Board	27/11
Rakovina Therapeutics Appoints Prof. Artem Cherkasov to the Scientific Advisory Board	27/11
Rakovina Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	27/11
Rakovina Therapeutics Announces Appointment of New Scientific Advisory Board Member	20/11
Rakovina Therapeutics Inc. Announces Appointment of Prof. Petra Hamerlik as New Scientific Advisory Board Member	20/11
Rakovina Therapeutics continues to make progress as company provides corporate update	13/09/23
Rakovina Therapeutics Inc. Announces Q2 2023 Financial Results and Provides Corporate Update	29/08/23
Rakovina Therapeutics Inc. Announces Q2 2023 Financial Results and Provides Corporate Update	29/08/23
Rakovina Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	29/08/23
Rakovina Therapeutics Announces Results from 2023 Annual General Meeting	29/06/23
Rakovina Therapeutics Inc. Announces Q1 2023 Financial Results and Provides Corporate Update	31/05/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Rakovina Therapeutics Inc.

Actions

RKV

CA75103L1013

Autres langues

Filtres